quinpirole has been researched along with Nerve Degeneration in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ganguly, A; Lee, D; Schultz, BJ; Wiemerslage, L | 1 |
| Lee, D; Wiemerslage, L | 1 |
| Meredith, GE; Napier, TC; Switzer, RC | 1 |
| Carey, RJ; Fornaguera, J; Huston, JP; Schwarting, RK | 1 |
| Boulu, R; Obrenovitch, T; Plotkine, M; Symon, L; Wahl, F | 1 |
| Sañudo-Peña, MC; Walker, JM | 1 |
| Pollack, AE; Strauss, JB | 1 |
7 other study(ies) available for quinpirole and Nerve Degeneration
| Article | Year |
|---|---|
Selective degeneration of dopaminergic neurons by MPP(+) and its rescue by D2 autoreceptors in Drosophila primary culture.
Topics: 1-Methyl-4-phenylpyridinium; Action Potentials; Animals; Animals, Genetically Modified; Bromocriptine; Cholinergic Neurons; Dopamine Agonists; Dopaminergic Neurons; Drosophila melanogaster; Drosophila Proteins; Female; GABAergic Neurons; Male; Nerve Degeneration; Parkinsonian Disorders; Primary Cell Culture; Quinpirole; Receptors, Dopamine D2 | 2013 |
Role of Drosophila calcium channel cacophony in dopaminergic neurodegeneration and neuroprotection.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Calcium Channels; Calcium Chelating Agents; Dopaminergic Neurons; Drosophila; Drosophila Proteins; Edetic Acid; Embryo, Nonmammalian; Mutation; Nerve Degeneration; Neuroprotective Agents; Parkinson Disease; Primary Cell Culture; Quinpirole; Receptors, Dopamine D2 | 2015 |
Short-term, D2 receptor blockade induces synaptic degeneration, reduces levels of tyrosine hydroxylase and brain-derived neurotrophic factor, and enhances D2-mediated firing in the ventral pallidum.
Topics: Animals; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Cell Survival; Disease Models, Animal; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Administration Schedule; Dyskinesia, Drug-Induced; Haloperidol; Immunohistochemistry; Male; Microscopy, Electron; Nerve Degeneration; Presynaptic Terminals; Prosencephalon; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Salicylamides; Synaptic Transmission; Tyrosine 3-Monooxygenase | 2004 |
Stimulation of D1- or D2-receptors in drug-naive rats with different degrees of unilateral nigro-striatal dopamine lesions.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Dopamine; Ergolines; Locomotion; Male; Nerve Degeneration; Oxidopamine; Parkinson Disease; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Substantia Nigra; Time Factors | 1995 |
Involvement of dopaminergic receptors in quinolinate-induced striatal lesions.
Topics: Animals; Corpus Striatum; Dopamine Agents; Dopamine Antagonists; Ergolines; Male; Necrosis; Nerve Degeneration; Quinolinic Acid; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Glutamate; Sulpiride | 1993 |
A novel neurotransmitter system involved in the control of motor behavior by the basal ganglia.
Topics: Action Potentials; Analgesics; Animals; Basal Ganglia; Benzoxazines; Bicuculline; Cannabinoids; Cyclohexanols; Dopamine; Dopamine Agonists; Electrophysiology; GABA Antagonists; gamma-Aminobutyric Acid; Morpholines; Motor Neurons; Naphthalenes; Nerve Degeneration; Neurotransmitter Agents; Oxidopamine; Piperidines; Pyrazoles; Quinpirole; Rats; Rimonabant; Sympatholytics; Thalamic Nuclei | 1998 |
Time dependence and role of N-methyl-D-aspartate glutamate receptors in the priming of D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats.
Topics: Animals; Apomorphine; Behavior, Animal; Brain Chemistry; Corpus Striatum; Dizocilpine Maleate; Dopamine Agonists; Excitatory Amino Acid Antagonists; Male; Nerve Degeneration; Oxidopamine; Piperazines; Proto-Oncogene Proteins c-fos; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Rotation; Sympatholytics; Time Factors | 1999 |